below is BUB's figures for 1H of FY19...
GROSS SALES $21.03MNET REVENUE $19.56MGROSS MARGIN* $3.75MNORMALISED EBITDA** ($3.52M)EBITDA** ($8.83M)
Their market cap is $334m @ 75c/share....
They are far more advanced in terms of marketing, branding etc but not in terms of revenue! and they are still losing money. They have hit an inflection point though with their revenues exploding recently.
I stll think JAT represents the better value for money if you are in the speculative game!
- Forums
- ASX - By Stock
- JAT
- Supply & Demand
Supply & Demand, page-56
-
-
- There are more pages in this discussion • 359 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.46M |
Open | High | Low | Value | Volume |
45.0¢ | 45.0¢ | 45.0¢ | $4.425K | 9.833K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 21502 | 45.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.0¢ | 33334 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 21502 | 0.450 |
1 | 50 | 0.425 |
3 | 22000 | 0.420 |
2 | 21300 | 0.410 |
4 | 40750 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.540 | 33334 | 1 |
0.550 | 51242 | 2 |
0.560 | 12073 | 3 |
0.590 | 20000 | 1 |
0.595 | 20000 | 1 |
Last trade - 15.40pm 12/11/2024 (20 minute delay) ? |
Featured News
JAT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online